These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24225488)

  • 21. Pharmacokinetic Evaluation of the Tau PET Radiotracer
    Wooten DW; Guehl NJ; Verwer EE; Shoup TM; Yokell DL; Zubcevik N; Vasdev N; Zafonte RD; Johnson KA; El Fakhri G; Normandin MD
    J Nucl Med; 2017 Mar; 58(3):484-491. PubMed ID: 27660144
    [No Abstract]   [Full Text] [Related]  

  • 22. Kinetic evaluation and test-retest reproducibility of [
    Finnema SJ; Nabulsi NB; Mercier J; Lin SF; Chen MK; Matuskey D; Gallezot JD; Henry S; Hannestad J; Huang Y; Carson RE
    J Cereb Blood Flow Metab; 2018 Nov; 38(11):2041-2052. PubMed ID: 28792356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [(11)C]diprenorphine test-retest data.
    Hammers A; Asselin MC; Turkheimer FE; Hinz R; Osman S; Hotton G; Brooks DJ; Duncan JS; Koepp MJ
    Neuroimage; 2007 Oct; 38(1):82-94. PubMed ID: 17764977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of GABAA receptor binding in vivo with [11C]flumazenil: a test-retest study in healthy subjects.
    Salmi E; Aalto S; Hirvonen J; Långsjö JW; Maksimow AT; Oikonen V; Metsähonkala L; Virkkala J; Någren K; Scheinin H
    Neuroimage; 2008 Jun; 41(2):260-9. PubMed ID: 18411060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
    Kim JS; Ichise M; Sangare J; Innis RB
    J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [3H]-nociceptin ligand-binding and nociceptin opioid receptor mrna expression in the human brain.
    Berthele A; Platzer S; Dworzak D; Schadrack J; Mahal B; Büttner A; Assmus HP; Wurster K; Zieglgänsberger W; Conrad B; Tölle TR
    Neuroscience; 2003; 121(3):629-40. PubMed ID: 14568023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.
    Naganawa M; Jacobsen LK; Zheng MQ; Lin SF; Banerjee A; Byon W; Weinzimmer D; Tomasi G; Nabulsi N; Grimwood S; Badura LL; Carson RE; McCarthy TJ; Huang Y
    Neuroimage; 2014 Oct; 99():69-79. PubMed ID: 24844744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling [
    Laurencin C; Lancelot S; Gobert F; Redouté J; Mérida I; Iecker T; Liger F; Irace Z; Greusard E; Lamberet L; Bars DL; Costes N; Ballanger B
    Neuroimage; 2021 Oct; 240():118328. PubMed ID: 34224852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of [¹⁸F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human.
    Hostetler ED; Sanabria-Bohórquez S; Eng W; Joshi AD; Patel S; Gibson RE; O'Malley S; Krause SM; Ryan C; Riffel K; Bi S; Okamoto O; Kawamoto H; Ozaki S; Ohta H; de Groot T; Bormans G; Depré M; de Hoon J; De Lepeleire I; Reynders T; Cook JJ; Burns HD; Egan M; Cho W; van Laere K; Hargreaves RJ
    Neuroimage; 2013 Mar; 68():1-10. PubMed ID: 23238431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
    Gavioli EC; Calo' G
    Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET.
    Milak MS; Severance AJ; Ogden RT; Prabhakaran J; Kumar JS; Majo VJ; Mann JJ; Parsey RV
    J Nucl Med; 2008 Apr; 49(4):587-96. PubMed ID: 18344443
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Koole M; Schmidt ME; Hijzen A; Ravenstijn P; Vandermeulen C; Van Weehaeghe D; Serdons K; Celen S; Bormans G; Ceusters M; Zhang W; Van Nueten L; Kolb H; de Hoon J; Van Laere K
    J Nucl Med; 2019 May; 60(5):683-690. PubMed ID: 30262518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors.
    Hillmer AT; Wooten DW; Bajwa AK; Higgins AT; Lao PJ; Betthauser TJ; Barnhart TE; Rowley HA; Stone CK; Johnson SC; Mukherjee J; Christian BT
    J Nucl Med; 2014 Dec; 55(12):1973-9. PubMed ID: 25453045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
    Zhang Y; Simpson-Durand CD; Standifer KM
    Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET quantification of brain O-GlcNAcase with [
    Lee JH; Liow JS; Paul S; Morse CL; Haskali MB; Manly L; Shcherbinin S; Ruble JC; Kant N; Collins EC; Nuthall HN; Zanotti-Fregonara P; Zoghbi SS; Pike VW; Innis RB
    EJNMMI Res; 2020 Mar; 10(1):20. PubMed ID: 32172476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibility.
    Staley JK; van Dyck CH; Weinzimmer D; Brenner E; Baldwin RM; Tamagnan GD; Riccardi P; Mitsis E; Seibyl JP
    J Nucl Med; 2005 Sep; 46(9):1466-72. PubMed ID: 16157529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
    Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
    Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone.
    Talbot PS; Slifstein M; Hwang DR; Huang Y; Scher E; Abi-Dargham A; Laruelle M
    Neuroimage; 2012 Jan; 59(1):271-85. PubMed ID: 21782029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative study of [Tyr10]nociceptin/orphanin FQ (1-11) at NOP receptors in rat periaqueductal gray and expressed NOP receptors in HEK293 cells.
    Liao YY; Lee CW; Ho IK; Chiou LC
    Life Sci; 2012 Feb; 90(7-8):306-12. PubMed ID: 22213115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First in-human PET study and kinetic evaluation of [
    Bhatt S; Nabulsi NB; Li S; Cai Z; Matuskey D; Bini J; Najafzadeh S; Kapinos M; Ropchan JR; Carson RE; Cosgrove KP; Huang Y; Hillmer AT
    J Cereb Blood Flow Metab; 2020 Apr; 40(4):695-704. PubMed ID: 30895878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.